A detailed history of High Tower Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 1,473,511 shares of ABBV stock, worth $247 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
1,473,511
Previous 1,435,201 2.67%
Holding current value
$247 Million
Previous $246 Million 18.21%
% of portfolio
0.43%
Previous 0.38%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $6.28 Million - $7.64 Million
38,310 Added 2.67%
1,473,511 $291 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $4.09 Million - $4.78 Million
-26,437 Reduced 1.81%
1,435,201 $246 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $12.3 Million - $14 Million
-76,699 Reduced 4.99%
1,461,638 $266 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $353,219 - $397,807
-2,567 Reduced 0.17%
1,538,337 $238 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $29.7 Million - $34.4 Million
222,183 Added 16.85%
1,540,904 $230 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $1 Million - $1.25 Million
-7,573 Reduced 0.57%
1,318,721 $178 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $6.89 Million - $7.94 Million
-47,670 Reduced 3.47%
1,326,294 $211 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $9.78 Million - $11.7 Million
70,736 Added 5.43%
1,373,964 $222 Million
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $97,033 - $111,291
723 Added 0.06%
1,303,228 $175 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $7.65 Million - $9.72 Million
-55,552 Reduced 4.09%
1,302,505 $200 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $88,954 - $110,367
-674 Reduced 0.05%
1,358,057 $220 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $6.96 Million - $8.81 Million
64,825 Added 5.01%
1,358,731 $184 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $2.68 Million - $3.04 Million
25,174 Added 1.98%
1,293,906 $139 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $14.5 Million - $16.1 Million
137,563 Added 12.16%
1,268,732 $143 Million
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $2.37 Million - $2.61 Million
23,176 Added 2.09%
1,131,169 $122 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $7.53 Million - $10.2 Million
93,570 Added 9.22%
1,107,993 $119 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $8.37 Million - $9.83 Million
97,443 Added 10.63%
1,014,423 $89 Million
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $6.08 Million - $8.14 Million
82,921 Added 9.94%
916,980 $90.1 Million
Q1 2020

May 21, 2020

BUY
$64.5 - $97.79 $6.64 Million - $10.1 Million
102,902 Added 14.07%
834,059 $63.6 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $1.8 Million - $2.25 Million
-24,901 Reduced 3.29%
731,157 $64.8 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $1.86 Million - $2.24 Million
29,523 Added 4.06%
756,058 $57.3 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $10.3 Million - $13.2 Million
157,369 Added 27.65%
726,535 $52.8 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $59,320 - $69,817
769 Added 0.14%
569,166 $45.8 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $3.43 Million - $4.23 Million
44,010 Added 8.39%
568,397 $52.4 Million
Q3 2018

Nov 09, 2018

BUY
$88.91 - $98.84 $2.8 Million - $3.11 Million
31,479 Added 6.39%
524,387 $49.6 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $1.71 Million - $2.02 Million
19,046 Added 4.02%
492,908 $45.7 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $3.11 Million - $4.16 Million
33,779 Added 7.68%
473,862 $44.9 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $11 Million - $12 Million
-122,441 Reduced 21.77%
440,083 $42.6 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $1.63 Million - $2.08 Million
-23,313 Reduced 3.98%
562,524 $50 Million
Q2 2017

Aug 14, 2017

BUY
N/A
585,837
585,837 $42.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.